Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
Author:
Affiliation:
1. Department of Medicine; University of Perugia, Hospital S.M. della Misericordia; Perugia Italy
2. Diabetes Research Group, Institute of Life Sciences, College of Medicine; Swansea University; Swansea UK
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12253/fullpdf
Reference64 articles.
1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012
2. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study;Alvarez Guisasola;Diabetes Obes Metab,2008
3. The biology of incretin hormones;Drucker;Cell Metab,2006
4. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide;Deacon;J Clin Endocrinol Metab,2000
5. Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects;Vilsbøll;J Clin Endocrinol Metab,2003
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04
2. The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy;Acta Diabetologica;2023-07-09
3. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy;Diabetologia;2023-05-20
4. Construction of multicopy glucagon-like peptide-1 (GLP-1) open reading frame and its expression in Escherichia coli;AIP Conference Proceedings;2023
5. Glycaemic variabilities: Key questions in pursuit of clarity;Diabetes & Metabolism;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3